NOTCH1 and hepatocellular carcinoma: The result showed that the combination of Rg3 and TACE prolonged OS than TACE monotherapy in HCC patients with high NOTCH1 expression.436 Later, Rg3 presented a synergistic anticancer effect for sorafenib in HCC cell lines and mouse model,437 which needs further preclinical and clinical exploration.